Quest Pharmatech Inc logo

QPT - Quest Pharmatech Inc Share Price

C$0.16 0.0  0.0%

Last Trade - 30/07/20

Micro Cap
Market Cap £15.3m
Enterprise Value £15.2m
Revenue £n/a
Position in Universe 1169th / 2677
Unlock QPT Revenue
Relative Strength (%)
1m -3.09%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -42.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Jan 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.96 0.23 0.003 0.039 0.000 0.000 -100.0%
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 30 April 2020, Quest PharmaTech Inc revenues was not reported. Net income before extraordinary items totaled C$106M vs. loss of C$1.7M. Net income reflects Foreign exchange gain/(loss) increase from C$160K (expense) to C$1K (income), Equity loss decrease from C$31K (expense) to C$0K. Basic Earnings per Share excluding Extraordinary Items increased from -C$0.01 to C$0.63.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


QPT Revenue Unlock QPT Revenue

Net Income

QPT Net Income Unlock QPT Revenue

Normalised EPS

QPT Normalised EPS Unlock QPT Revenue

PE Ratio Range

QPT PE Ratio Range Unlock QPT Revenue

Dividend Yield Range

QPT Dividend Yield Range Unlock QPT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
QPT EPS Forecasts Unlock QPT Revenue
Profile Summary

Quest PharmaTech Inc. is a Canada-based pharmaceutical company. The Company, through its subsidiary, OncoQuest Inc., is developing immunotherapies for cancer treatment. It operates through two segments: biopharmaceutical/pharmaceutical products and consumer/cosmetic products. OncoQuest's technology platform includes a panel of tumor antigen specific monoclonal immunoglobulins, including CA125, MUC1, PSA, and Her2/neu, and the application of combinatorial immunotherapy. OncoQuest's lead product, oregovomab, is undergoing a Phase IIb clinical trial involving approximately 80 ovarian cancer patients in Italy and the United States. OncoQuest's pipeline of product candidates consists of four other monoclonal antibodies targeting certain tumor antigens that are presented in a range of cancers, including such cancers as breast, lung, pancreas, stomach and prostate. It also markets consumer health products around the world, including Bellus Skin serum, an anti-wrinkle skin care product.

Last Annual January 31st, 2020
Last Interim April 30th, 2020
Incorporated December 16, 1996
Public Since July 23, 1997
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange TSX Venture Exchange
Shares in Issue 167,749,247
Free Float (0.0%)
Eligible for
QPT Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for QPT
Upcoming Events for QPT
Frequently Asked Questions for Quest Pharmatech Inc
What is the Quest Pharmatech Inc share price?

As of 30/07/20, shares in Quest Pharmatech Inc are trading at C$0.16, giving the company a market capitalisation of £15.3m. This share price information is delayed by 15 minutes.

How has the Quest Pharmatech Inc share price performed this year?

Shares in Quest Pharmatech Inc are currently trading at C$0.16 and the price has moved by 39.13% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Quest Pharmatech Inc price has moved by 38.96% over the past year.

What are the analyst and broker recommendations for Quest Pharmatech Inc?

There are no analysts currently covering Quest Pharmatech Inc.

When will Quest Pharmatech Inc next release its financial results?

Quest Pharmatech Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-04-30
What is the Quest Pharmatech Inc dividend yield?

Quest Pharmatech Inc does not currently pay a dividend.

Does Quest Pharmatech Inc pay a dividend?

Quest Pharmatech Inc does not currently pay a dividend.

When does Quest Pharmatech Inc next pay dividends?

Quest Pharmatech Inc does not currently pay a dividend.

How do I buy Quest Pharmatech Inc shares?

To buy shares in Quest Pharmatech Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Quest Pharmatech Inc?

Shares in Quest Pharmatech Inc are currently trading at C$0.16, giving the company a market capitalisation of £15.3m.

Where are Quest Pharmatech Inc shares listed? Where are Quest Pharmatech Inc shares listed?

Here are the trading details for Quest Pharmatech Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: QPT
What kind of share is Quest Pharmatech Inc?

Based on an overall assessment of its quality, value and momentum, Quest Pharmatech Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Quest Pharmatech Inc share price forecast 2020?

We were not able to load any forecast data for Quest Pharmatech Inc.

How can I tell whether the Quest Pharmatech Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Quest Pharmatech Inc. Over the past six months, the relative strength of its shares against the market has been 52.8%. At the current price of C$0.16, shares in Quest Pharmatech Inc are trading at 20.5% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Quest Pharmatech Inc PE Ratio?

The Quest Pharmatech Inc PE ratio based on its reported earnings over the past 12 months is 0.27. The shares are currently trading at C$0.16.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Quest Pharmatech Inc?

Quest Pharmatech Inc's management team is headed by:

Thomas Woo - VPR
Ragupathy Madiyalakan - CEO
Lorne Meikle - CHM
Shawn Shuguang Lu - DRC
Eric Shi - IND
Hany Awadalla - CFO
J. Mark Lievonen - DRC
Who are the major shareholders of Quest Pharmatech Inc?

Here are the top five shareholders of Quest Pharmatech Inc based on the size of their shareholding:

HEPALINK USA, Inc. Corporation
Percentage owned: 14.9% (25.0m shares)
Madiyalakan (Ragupathy) Individual Investor
Percentage owned: 1.61% (2.70m shares)
Meikle (Lorne) Individual Investor
Percentage owned: 0.03% (52.0k shares)
Meekison (William John) Individual Investor
Percentage owned: 0.01% (10.00k shares)
Huang (Bin Ph.D.) Individual Investor
Percentage owned: 0.01% (20.0k shares)
Similar to QPT
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.